CSCMY Financial Statements & Analysis
Complete financial statements for CSCMY including income statement, balance sheet, and cash flow statement. Analyze CSCMY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
10.4% ↑
Net Income
42.7% ↑
Gross Margin
-2.4% ↓
Operating Margin
18.5% ↑
Balance Sheet
Current Ratio
355.1% ↑
Debt to Equity
-76.4% ↑
Asset Turnover
-4.7% ↓
Cash Flow
Operating Cash Flow
63.3% ↑
Net Cash Flow
818.5% ↑
Free Cash Flow
60.8% ↑
Cash Flow to Debt
343.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 172.92M | 190.90M | 10.4% | |
| Gross Profit | 42.48M | 45.79M | 7.8% | |
| Operating Income | 11.18M | 14.62M | 30.8% | |
| Net Income | 5.47M | 7.81M | 42.7% | |
| EPS | 0.01 | 0.01 | 29.2% | |
| EBITDA | 56.90M | 52.59M | 7.6% | |
| Gross Margin | 24.57% | 23.99% | 2.4% | |
| Operating Margin | 6.47% | 7.66% | 18.5% | |
| Net Income Margin | 3.17% | 4.09% | 29.3% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 190.90M | 172.92M | 178.71M | — | — |
| Gross Profit | 45.79M | 42.48M | 40.35M | — | — |
| Operating Income | 14.62M | 11.18M | 12.08M | — | — |
| Net Income | 7.81M | 5.47M | 1.90M | — | — |
| EPS | 0.01 | 0.01 | 0.00 | — | — |
| EBITDA | 52.59M | 56.90M | 60.57M | — | — |
| Gross Margin | 23.99% | 24.57% | 22.58% | — | — |
| Operating Margin | 7.66% | 6.47% | 6.76% | — | — |
| Net Income Margin | 4.09% | 3.17% | 1.06% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into CSCMY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics